Cancer Family
Respiratory System Neoplasm
CI-CAN-00000049Explore in graph →
Non-malignant2,727 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000049Explore in graph →
Clinical trials
11,614 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03427541 | A Study to Explore Prognoses of NSCLC Patients Complicated With Oligometastases | unknown | — | 1,000 | Tang-Du HospitalOTHER | 1 | Feb 9, 2018 | clinicaltrials |
| NCT03424759 | Uncommon EGFR AZD9291 | unknown | Phase 2 | 37 | Samsung Medical CenterOTHER | 1 | Feb 7, 2018 | clinicaltrials |
| NCT02151721 |
| Phase I of Vorinostat-Iressa Combined Therapy on Resistance by BIM Polymorphysim in EGFR Mutant Lung Cancer(VICTORY-J) |
| unknown |
| Phase 1 |
| 12 |
| Kanazawa UniversityOTHER |
| 1 |
| Feb 5, 2018 |
| clinicaltrials |
| NCT03416231 | Apatinib Plus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer(NSCLC) | unknown | Phase 2 | 20 | Affiliated Hospital of North Sichuan Medical CollegeOTHER | 1 | Jan 31, 2018 | clinicaltrials |
| NCT03416972 | Detecting Radiation-Induced Cardiac Toxicity After Non-Small Cell Lung Cancer Radiotherapy(RICT-LUNG) | unknown | — | 20 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Jan 31, 2018 | clinicaltrials |
| NCT03413358 | Clinical Trial for Post-marketing Evaluation of Sheng Bai Oral Liquid | unknown | N/A | 240 | BeiJing Yijiayi Medicine Techonoloy Co., Ltd.INDUSTRY | 1 | Jan 29, 2018 | clinicaltrials |
| NCT03411967 | Apatinib in Combination With Docetaxel for Patients With Advanced NSCLC | unknown | Phase 2 | 20 | Zigong No.1 Peoples HospitalOTHER | 0 | Jan 26, 2018 | clinicaltrials |
| NCT03391557 | Significance of Ultrasound Elastography in Lymph Node | unknown | N/A | 42 | FangsurongOTHER | 0 | Jan 25, 2018 | clinicaltrials |
| NCT02734524 | A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer | unknown | Phase 2 | 104 | Southwest Hospital, ChinaOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT02852083 | A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLC(ModuLung) | unknown | Phase 2 | 86 | University Hospital RegensburgOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT02934360 | TR(ACE) Assay Clinical Specimen Study | unknown | — | 450 | Biological DynamicsINDUSTRY | 1 | Jan 18, 2018 | clinicaltrials |
| NCT03127319 | A Study of Apatinib Plus Docetaxel for Treatment of Advanced Non-squamous Non-small Cell Lung Cancer With Bone Metastases | unknown | Phase 2 | 40 | Affiliated Hospital of Hebei UniversityOTHER | 1 | Jan 17, 2018 | clinicaltrials |
| NCT03399669 | The Continuation of Gefitinib Treatment Beyond Progression in Non-small Cell Lung Cancer Patients With EGFR Mutation | unknown | Phase 2 | 100 | Samsung Medical CenterOTHER | 1 | Jan 16, 2018 | clinicaltrials |
| NCT03384680 | Symptom Collection of Lung Cancer Patients | unknown | — | 100 | Seong-Gyu KoOTHER | 1 | Jan 9, 2018 | clinicaltrials |
| NCT03394703 | Korean Lung Cancer Screening Project(K-LUCAS) | unknown | — | 8,000 | National Cancer Center, KoreaOTHER_GOV | 1 | Jan 9, 2018 | clinicaltrials |
| NCT03392506 | EBUS-TBNA-RTE VS Radiography in Staging of NSCLC | unknown | N/A | 120 | Jiayuan SunOTHER | 1 | Jan 8, 2018 | clinicaltrials |
| NCT03381430 | Gefitinib Combine Radiotherapy as Therapy for Patients With NSCLC Harbouring Sensitive Mutations of EGFR | unknown | N/A | 50 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 1 | Dec 22, 2017 | clinicaltrials |
| NCT02410369 | Study of S-588410 After Adjuvant Chemotherapy for Completely Resected Non-small- Cell Lung Cancer | unknown | Phase 2 | 60 | Tokyo UniversityOTHER | 1 | Dec 21, 2017 | clinicaltrials |
| NCT03376191 | Apatinib in Advanced Non-squamous，NSCLC | unknown | — | 100 | Jian FangOTHER | 1 | Dec 18, 2017 | clinicaltrials |
| NCT03376737 | Study of Apatinib as the Maintenance Therapy in Advanced Lung Adenocarcinoma | unknown | Phase 2 | 120 | Henan Cancer HospitalOTHER_GOV | 1 | Dec 18, 2017 | clinicaltrials |
| NCT03135977 | Apatinib and Etoposide as the Maintenance Therapy in Extensive-stage Small Cell Lung Cancer After First-line Chemotherapy | unknown | Phase 2 | 36 | Sichuan Cancer Hospital and Research InstituteOTHER | 1 | Dec 7, 2017 | clinicaltrials |
| NCT03357094 | Pulmonary Ventilation/Perfusion Imaging for the Prediction of Postoperative Residual Pulmonary Function | unknown | — | 50 | Beijing Tongren HospitalOTHER | 1 | Nov 29, 2017 | clinicaltrials |
| NCT03201146 | Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC | unknown | Phase 1 / Phase 2 | 48 | West China HospitalOTHER | 1 | Nov 17, 2017 | clinicaltrials |
| NCT03341494 | EGFR Mutation Positive NSCLC Patients With Gefitinib and Thalidomide | unknown | Phase 2 | 128 | Fujian Cancer HospitalOTHER_GOV | 1 | Nov 14, 2017 | clinicaltrials |
| NCT03262948 | Nab-Paclitaxel Versus Paclitaxel Plus Carboplatin in Advanced Squamous Cell Non Small Cell Lung Cancer | unknown | Phase 3 | 388 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 0 | Nov 13, 2017 | clinicaltrials |
| NCT02397239 | Comparison of Cost-effectiveness of Continuation Maintenance Therapy With Six Cycles of Pemetrexed Versus Pemetrexed Until Disease Progression for Metastatic Non-squamous Non-small-cell Lung Cancer | unknown | — | 72 | National Cheng-Kung University HospitalOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT03331575 | Hypofractionated vs. Conventionally Fractionated Concurrent CRT for Unresectable Stage III NSCLC(HCFCCUSN) | unknown | Phase 3 | 480 | Shanghai Chest HospitalOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT02714010 | EGFR-TKI Concurrent With/Without WBRT in Brain Metastasis From NSCLC | unknown | Phase 3 | 601 | Sun Yat-sen UniversityOTHER | 1 | Oct 27, 2017 | clinicaltrials |
| NCT02607605 | A Prospective, Observational Trial on the Diagnostic and Prognostic of LM(ctDNA) | unknown | — | 10 | Sun Yat-sen UniversityOTHER | 1 | Oct 26, 2017 | clinicaltrials |
| NCT02499614 | Crizotinib in Pretreated Metastatic Non-small-cell Lung Cancer With MET Amplification or ROS1 Translocation (METROS)(METROS) | unknown | Phase 2 | 80 | Fondazione Ricerca TraslazionaleOTHER | 1 | Oct 25, 2017 | clinicaltrials |
| NCT02844608 | Feasibility of Quality of Life Assessment in Routine Clinical Oncology Practice at the University Hospital of Besancon(QOLIBRY) | unknown | N/A | 152 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Oct 13, 2017 | clinicaltrials |
| NCT03152071 | Comparison of Robot Assisted Thoracic Surgery With Video Assisted Thoracic Surgery in Case of Lung Cancer | unknown | N/A | 30 | Universitair Ziekenhuis BrusselOTHER | 1 | Oct 9, 2017 | clinicaltrials |
| NCT03198923 | Clinical Efficacy and Safety of NK and NKT Cells Infusion in Patients With Non Small Cell Lung Cancer | unknown | Phase 1 | 30 | Wenxiang WangOTHER | 1 | Sep 25, 2017 | clinicaltrials |
| NCT02455843 | Microwave Plus Chemotherapy Versus Chemotherapy for Advanced NSCLC | unknown | Phase 3 | 275 | Shandong Provincial HospitalOTHER_GOV | 1 | Sep 19, 2017 | clinicaltrials |
| NCT02894853 | Lung Cancer Early Molecular Assessment Trial(LEMA) | unknown | — | 1,297 | The Netherlands Cancer InstituteOTHER | 1 | Sep 14, 2017 | clinicaltrials |
| NCT03269162 | Postoperative NSCLC Treated With Integrated Medicine Base on Circulating Tumor Cell Detection | unknown | Phase 3 | 144 | lihegenOTHER | 0 | Sep 14, 2017 | clinicaltrials |
| NCT03282435 | Treatment of Non-small Cell Lung Cancer With Cytokine-induced Killer (CIK) Cells Blocked by PD-1 Antibody | unknown | Phase 1 | 30 | Dalian UniversityOTHER | 0 | Sep 14, 2017 | clinicaltrials |
| NCT02995187 | Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC) | unknown | Phase 2 | 25 | Chinese Academy of Medical SciencesOTHER | 1 | Sep 7, 2017 | clinicaltrials |
| NCT03264794 | the Clinical Trial of Gefitinib(Non - Small Cell Lung Cancer) | unknown | Phase 4 | 100 | Jiangsu Famous Medical Technology Co., Ltd.INDUSTRY | 0 | Aug 29, 2017 | clinicaltrials |
| NCT03258671 | IMRT and Timing in Combination With EGFRTKI for Stage IV Non-small-cell Lung Cancer | unknown | N/A | 160 | LuBingOTHER | 1 | Aug 25, 2017 | clinicaltrials |
| NCT02423590 | Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung Cancers | unknown | Phase 2 | 140 | Queen Mary University of LondonOTHER | 1 | Aug 22, 2017 | clinicaltrials |
| NCT03257735 | A Study of the Gene Mutation Status in Cerebrospinal Fluid, Blood and Tumor Tissue of Non-small Cell Lung Cancer Patients With Brain Metastases | unknown | — | 50 | Sun Yat-sen UniversityOTHER | 1 | Aug 22, 2017 | clinicaltrials |
| NCT02515435 | The Efficacy and Safety of Apatinib in Heavily Pretreated Advanced Non-squamous Non-small Cell Lung Cancer | unknown | Phase 2 | 40 | Tongji UniversityOTHER | 1 | Aug 18, 2017 | clinicaltrials |
| NCT03065764 | 89Zr-labeled Pembrolizumab in Patients With Non-small-cell Lung Cancer | unknown | Phase 2 | 10 | Amsterdam UMC, location VUmcOTHER | 1 | Aug 17, 2017 | clinicaltrials |
| NCT03244904 | Next-generation Sequencing of Small Cell Lung Cancer to Identify Susceptibility Gene and to Assess Treatment | unknown | — | 80 | Fujian Cancer HospitalOTHER_GOV | 0 | Aug 10, 2017 | clinicaltrials |
| NCT02404675 | High Dose Icotinib in Advanced Non-small Cell Lung Cancer With EGFR 21 Exon Mutation(INCREASE) | unknown | Phase 4 | 240 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 28, 2017 | clinicaltrials |
| NCT03231111 | The Effectiveness of Using Preventive Multimedia Teaching Program in Lung Cancer Women Receiving Targeted Therapy on Skin-Related Quality of Life | unknown | N/A | 60 | National Taiwan University HospitalOTHER | 1 | Jul 27, 2017 | clinicaltrials |
| NCT03219762 | Study of Nab-paclitaxel in Sensitive and Refractory Relapsed SCLC(Nabster) | unknown | Phase 2 | 65 | Gruppo Oncologico Italiano di Ricerca ClinicaOTHER | 1 | Jul 26, 2017 | clinicaltrials |
| NCT00385164 | The Utility of FDG-PET for Radiation Treatment in NSCLC | unknown | — | 50 | AHS Cancer Control AlbertaOTHER | 1 | Jul 25, 2017 | clinicaltrials |
Data updated 24 days agoSource updated Feb 9, 2018source: clinicaltrials